A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor ConsortiumIan F. Pollack, J. Russell Geyer, Clinton F. Stewart et al.|Neuro-Oncology|2011Cited by 130
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A. Upadhyaya, Amar Gajjar, Arzu Onar‐Thomas et al.|Neuro-Oncology|2022Cited by 29